Bendamustine combined with rituximab for patients with relapsed or refractory diffuse large B cell lymphoma

Multicenter Phase II Study of Bendamustine Plus Rituximab in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

(2013) Ken Ohmachi et al.   JOURNAL OF CLINICAL ONCOLOGY

Treatment option of bendamustine in combination with rituximab in elderly and frail patients with aggressive B-non-Hodgkin lymphoma: rational, efficacy, and tolerance

(2012) Julia Horn et al.   ANNALS OF HEMATOLOGY

Bendamustine with or without rituximab for the treatment of heavily pretreated non-Hodgkin’s lymphoma patients

(2012) Luigi Rigacci et al.   ANNALS OF HEMATOLOGY

Inhibitors of B-Cell Receptor Signaling for Patients With B-Cell Malignancies

(2012) Michael Y. Choi et al.   CANCER JOURNAL

Rituximab and bendamustine in patients with CD20+ diffuse large B-cell lymphoma not eligible for cyclophosphamide, doxorubicin, vincristine and prednisone-like chemotherapy

(2012) Eva Walter et al.   LEUKEMIA & LYMPHOMA

SYK inhibition and response prediction in diffuse large B-cell lymphoma

(2011) S. Cheng et al.   BLOOD

Higher response to lenalidomide in relapsed/refractory diffuse large B-cell lymphoma in nongerminal center B-cell-like than in germinal center B-cell-like phenotype

(2011) Francisco J. Hernandez-Ilizaliturri et al.   CANCER

CAL-101, a p110  selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability

(2010) B. J. Lannutti et al.   BLOOD

Double-hit B-cell lymphomas

(2010) S. M. Aukema et al.   BLOOD

Efficacy of bendamustine in rituximab-refractory indolent B-cell non-Hodgkin lymphoma: review of a pivotal trial

(2010) Chaitra Ujjani et al.   Future Oncology

Salvage Regimens With Autologous Transplantation for Relapsed Large B-Cell Lymphoma in the Rituximab Era

(2010) Christian Gisselbrecht et al.   JOURNAL OF CLINICAL ONCOLOGY

Efficacy of bendamustine as salvage treatment in an heavily pre-treated Hodgkin lymphoma

(2010) Gianna Maria D’Elia et al.   LEUKEMIA RESEARCH

Long-term results of gemcitabine plus oxaliplatin with and without rituximab as salvage treatment for transplant-ineligible patients with refractory/relapsing B-cell lymphoma

(2009) Gaetano Corazzelli et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Bendamustine: Rebirth of an Old Drug

(2009) Bruce D. Cheson et al.   JOURNAL OF CLINICAL ONCOLOGY

Classification of lymphoid neoplasms: the microscope as a tool for disease discovery

(2008) E. S. Jaffe et al.   BLOOD

Diffuse Large B-Cell Lymphoma

(2008) Jonathan W. Friedberg et al.   HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA